Parabilis Medicines, Inc. (NASDAQ:PBLS – Get Free Report) major shareholder Guy Levy purchased 500,000 shares of Parabilis Medicines stock in a transaction on Thursday, June 11th. The stock was bought at an average price of $20.00 per share, for a total transaction of $10,000,000.00. Following the transaction, the insider directly owned 1,027,000 shares in the company, valued at approximately $20,540,000. The trade was a 94.88% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Major shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.
Parabilis Medicines Stock Performance
Shares of PBLS traded up $0.72 during mid-day trading on Monday, reaching $29.52. 131,079 shares of the company were exchanged, compared to its average volume of 1,137,350. Parabilis Medicines, Inc. has a 52 week low of $24.51 and a 52 week high of $34.47.
Analyst Ratings Changes
Separately, Wall Street Zen raised shares of Parabilis Medicines to a “hold” rating in a research note on Saturday, June 20th.
Featured Stories
- Five stocks we like better than Parabilis Medicines
- Is McCormick a Steal Ahead of Game-Changing Unilever Deal?
- Qualcomm’s Investor Day Just Changed the Growth Story Forever
- JPMorgan Stands by Sky-High Broadcom Target as Shares Slide
- 5 Places Investors Can Hide If the AI Trade Keeps Cracking
Receive News & Ratings for Parabilis Medicines Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Parabilis Medicines and related companies with MarketBeat.com's FREE daily email newsletter.
